Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
171.79(c) 171.87(c) 172.66(c) 172.18(c) 172.18(c) Last
5 015 073 4 485 035 7 089 269 5 750 714 4 206 501 Volume
+1.06% +0.05% +0.46% -0.28% 0.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 94 452 M - -
Net income 2021 22 808 M - -
Net Debt 2021 853 M - -
P/E ratio 2021 20,2x
Yield 2021 2,41%
Sales 2022 97 514 M - -
Net income 2022 23 818 M - -
Net cash position 2022 5 580 M - -
P/E ratio 2022 18,7x
Yield 2022 2,57%
Capitalization 453 B 453 B -
EV / Sales 2021 4,81x
EV / Sales 2022 4,59x
Nbr of Employees 134 500
Free-Float 84,3%
More Financials
Company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care,... 
Sector
Pharmaceuticals
Calendar
08/23Ex-dividend day for
More about the company
Ratings of Johnson & Johnson
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about JOHNSON & JOHNSON
04:19pJOHNSON & JOHNSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
01:01pEMERGENT BIOSOLUTIONS : resumes COVID-19 vaccine production
AQ
12:06pJOHNSON & JOHNSON : SA to Soon Administer Over 300,000 Covid-19 Vaccines a Day
AQ
11:16aJOHNSON & JOHNSON : Women Cancer Victims Opposed to Johnson & Johnson's 'Texas T..
PR
11:06aJOHNSON & JOHNSON : and Vaccine Gets Approval
AQ
10:04aJOHNSON & JOHNSON : Statement on U.S. FDA Approval of Shelf Life Extension for C..
AQ
09:33aBIOHIT OYJ : Appoints New CEO
MT
05:44aLABORATORIO REIG JOFRE S A : Reig Jofre Delays Manufacturing of Johnson & Johnso..
MT
02:01aBIOHIT OYJ : Päivi Siltala new CEO of Biohit Oyj
AQ
12:08aJOHNSON & JOHNSON : What is a COVID-19 vaccine 'breakthrough' case?
AQ
07/28JOHNSON & JOHNSON : Statement on U.S. FDA Approval of Shelf Life Extension for C..
PU
07/28JOHNSON & JOHNSON : US extends expiration dates on J&J COVID vaccine to 6 months
AQ
07/28JOHNSON & JOHNSON : Liberia Vows to Meet WHO's Benchmark As the U.S Donated Vacc..
AQ
07/28JOHNSON & JOHNSON : Aspen - STEPHEN SAAD DISCUSSES THE J&J VACCINE RELEASE WITH ..
AQ
07/28THE LATEST : CDC leader: Masks, vaccination could halt surge
AQ
More news
News in other languages on JOHNSON & JOHNSON
09:37aJ&J-Auftragsfertiger kann Impfstoffproduktion nach Panne wieder aufnehmen
05:30aEMERGENT BIOSOLUTIONS : reprise de la production de vaccins Johnson & Johnson
05:08aPLANÈTE BOURSE : La revue de presse du jeudi 29 juillet 2021
07/28L'argent coule à flots pour Pfizer grâce à son sérum contre le Covid-19
07/27EU erreicht Etappenziel bei Impfkampagne
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 172,18 $
Average target price 184,35 $
Spread / Average Target 7,07%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.18.04%243 220
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750
ABBVIE INC.10.64%209 386